Global Female Contraceptives Supply, Demand and Key Producers, 2023-2029

Description

This report studies the global Female Contraceptives demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Female Contraceptives, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Female Contraceptives that contribute to its increasing demand across many markets.

The global Female Contraceptives market size is expected to reach $ 22510 million by 2029, rising at a market growth of 2.5% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Female Contraceptives total market, 2018-2029, (USD Million)
Global Female Contraceptives total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Female Contraceptives total market, key domestic companies and share, (USD Million)
Global Female Contraceptives revenue by player and market share 2018-2023, (USD Million)
Global Female Contraceptives total market by Type, CAGR, 2018-2029, (USD Million)
Global Female Contraceptives total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Female Contraceptives market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, Merck, Johnson & Johnson, Lupin Pharmaceuticals and Female Health Company, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Female Contraceptives market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Female Contraceptives Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Female Contraceptives Market, Segmentation by Type
    Contraceptive Drugs
    Contraceptive Devices

Global Female Contraceptives Market, Segmentation by Application
    Personal use
    Hospital

Companies Profiled:
    Bayer
    Mayer Laboratories
    Pfizer
    Mylan
    Teva
    Merck
    Johnson & Johnson
    Lupin Pharmaceuticals
    Female Health Company
    Fuji Latex

Key Questions Answered
1. How big is the global Female Contraceptives market?
2. What is the demand of the global Female Contraceptives market?
3. What is the year over year growth of the global Female Contraceptives market?
4. What is the total value of the global Female Contraceptives market?
5. Who are the major players in the global Female Contraceptives market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Female Contraceptives Introduction
    1.2 World Female Contraceptives Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Female Contraceptives Total Market by Region (by Headquarter Location)
        1.3.1 World Female Contraceptives Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Female Contraceptives Market Size (2018-2029)
        1.3.3 China Female Contraceptives Market Size (2018-2029)
        1.3.4 Europe Female Contraceptives Market Size (2018-2029)
        1.3.5 Japan Female Contraceptives Market Size (2018-2029)
        1.3.6 South Korea Female Contraceptives Market Size (2018-2029)
        1.3.7 ASEAN Female Contraceptives Market Size (2018-2029)
        1.3.8 India Female Contraceptives Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Female Contraceptives Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Female Contraceptives Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Female Contraceptives Consumption Value (2018-2029)
    2.2 World Female Contraceptives Consumption Value by Region
        2.2.1 World Female Contraceptives Consumption Value by Region (2018-2023)
        2.2.2 World Female Contraceptives Consumption Value Forecast by Region (2024-2029)
    2.3 United States Female Contraceptives Consumption Value (2018-2029)
    2.4 China Female Contraceptives Consumption Value (2018-2029)
    2.5 Europe Female Contraceptives Consumption Value (2018-2029)
    2.6 Japan Female Contraceptives Consumption Value (2018-2029)
    2.7 South Korea Female Contraceptives Consumption Value (2018-2029)
    2.8 ASEAN Female Contraceptives Consumption Value (2018-2029)
    2.9 India Female Contraceptives Consumption Value (2018-2029)

3 World Female Contraceptives Companies Competitive Analysis
    3.1 World Female Contraceptives Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Female Contraceptives Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Female Contraceptives in 2022
        3.2.3 Global Concentration Ratios (CR8) for Female Contraceptives in 2022
    3.3 Female Contraceptives Company Evaluation Quadrant
    3.4 Female Contraceptives Market: Overall Company Footprint Analysis
        3.4.1 Female Contraceptives Market: Region Footprint
        3.4.2 Female Contraceptives Market: Company Product Type Footprint
        3.4.3 Female Contraceptives Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Female Contraceptives Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Female Contraceptives Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Female Contraceptives Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Female Contraceptives Consumption Value Comparison
        4.2.1 United States VS China: Female Contraceptives Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Female Contraceptives Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Female Contraceptives Companies and Market Share, 2018-2023
        4.3.1 United States Based Female Contraceptives Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Female Contraceptives Revenue, (2018-2023)
    4.4 China Based Companies Female Contraceptives Revenue and Market Share, 2018-2023
        4.4.1 China Based Female Contraceptives Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Female Contraceptives Revenue, (2018-2023)
    4.5 Rest of World Based Female Contraceptives Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Female Contraceptives Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Female Contraceptives Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Female Contraceptives Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Contraceptive Drugs
        5.2.2 Contraceptive Devices
    5.3 Market Segment by Type
        5.3.1 World Female Contraceptives Market Size by Type (2018-2023)
        5.3.2 World Female Contraceptives Market Size by Type (2024-2029)
        5.3.3 World Female Contraceptives Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Female Contraceptives Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Personal use
        6.2.2 Hospital
    6.3 Market Segment by Application
        6.3.1 World Female Contraceptives Market Size by Application (2018-2023)
        6.3.2 World Female Contraceptives Market Size by Application (2024-2029)
        6.3.3 World Female Contraceptives Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Female Contraceptives Product and Services
        7.1.4 Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Mayer Laboratories
        7.2.1 Mayer Laboratories Details
        7.2.2 Mayer Laboratories Major Business
        7.2.3 Mayer Laboratories Female Contraceptives Product and Services
        7.2.4 Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Mayer Laboratories Recent Developments/Updates
        7.2.6 Mayer Laboratories Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer Female Contraceptives Product and Services
        7.3.4 Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 Mylan
        7.4.1 Mylan Details
        7.4.2 Mylan Major Business
        7.4.3 Mylan Female Contraceptives Product and Services
        7.4.4 Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Mylan Recent Developments/Updates
        7.4.6 Mylan Competitive Strengths & Weaknesses
    7.5 Teva
        7.5.1 Teva Details
        7.5.2 Teva Major Business
        7.5.3 Teva Female Contraceptives Product and Services
        7.5.4 Teva Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Teva Recent Developments/Updates
        7.5.6 Teva Competitive Strengths & Weaknesses
    7.6 Merck
        7.6.1 Merck Details
        7.6.2 Merck Major Business
        7.6.3 Merck Female Contraceptives Product and Services
        7.6.4 Merck Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Merck Recent Developments/Updates
        7.6.6 Merck Competitive Strengths & Weaknesses
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Details
        7.7.2 Johnson & Johnson Major Business
        7.7.3 Johnson & Johnson Female Contraceptives Product and Services
        7.7.4 Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Johnson & Johnson Recent Developments/Updates
        7.7.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.8 Lupin Pharmaceuticals
        7.8.1 Lupin Pharmaceuticals Details
        7.8.2 Lupin Pharmaceuticals Major Business
        7.8.3 Lupin Pharmaceuticals Female Contraceptives Product and Services
        7.8.4 Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Lupin Pharmaceuticals Recent Developments/Updates
        7.8.6 Lupin Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Female Health Company
        7.9.1 Female Health Company Details
        7.9.2 Female Health Company Major Business
        7.9.3 Female Health Company Female Contraceptives Product and Services
        7.9.4 Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Female Health Company Recent Developments/Updates
        7.9.6 Female Health Company Competitive Strengths & Weaknesses
    7.10 Fuji Latex
        7.10.1 Fuji Latex Details
        7.10.2 Fuji Latex Major Business
        7.10.3 Fuji Latex Female Contraceptives Product and Services
        7.10.4 Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Fuji Latex Recent Developments/Updates
        7.10.6 Fuji Latex Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Female Contraceptives Industry Chain
    8.2 Female Contraceptives Upstream Analysis
    8.3 Female Contraceptives Midstream Analysis
    8.4 Female Contraceptives Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Female Contraceptives Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Female Contraceptives Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Female Contraceptives Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Female Contraceptives Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Female Contraceptives Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Female Contraceptives Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Female Contraceptives Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Female Contraceptives Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Female Contraceptives Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Female Contraceptives Players in 2022
    Table 12. World Female Contraceptives Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Female Contraceptives Company Evaluation Quadrant
    Table 14. Head Office of Key Female Contraceptives Player
    Table 15. Female Contraceptives Market: Company Product Type Footprint
    Table 16. Female Contraceptives Market: Company Product Application Footprint
    Table 17. Female Contraceptives Mergers & Acquisitions Activity
    Table 18. United States VS China Female Contraceptives Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Female Contraceptives Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Female Contraceptives Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Female Contraceptives Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Female Contraceptives Revenue Market Share (2018-2023)
    Table 23. China Based Female Contraceptives Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Female Contraceptives Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Female Contraceptives Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Female Contraceptives Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Female Contraceptives Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Female Contraceptives Revenue Market Share (2018-2023)
    Table 29. World Female Contraceptives Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Female Contraceptives Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Female Contraceptives Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Female Contraceptives Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Female Contraceptives Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Female Contraceptives Market Size by Application (2024-2029) & (USD Million)
    Table 35. Bayer Basic Information, Area Served and Competitors
    Table 36. Bayer Major Business
    Table 37. Bayer Female Contraceptives Product and Services
    Table 38. Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Bayer Recent Developments/Updates
    Table 40. Bayer Competitive Strengths & Weaknesses
    Table 41. Mayer Laboratories Basic Information, Area Served and Competitors
    Table 42. Mayer Laboratories Major Business
    Table 43. Mayer Laboratories Female Contraceptives Product and Services
    Table 44. Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Mayer Laboratories Recent Developments/Updates
    Table 46. Mayer Laboratories Competitive Strengths & Weaknesses
    Table 47. Pfizer Basic Information, Area Served and Competitors
    Table 48. Pfizer Major Business
    Table 49. Pfizer Female Contraceptives Product and Services
    Table 50. Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Pfizer Recent Developments/Updates
    Table 52. Pfizer Competitive Strengths & Weaknesses
    Table 53. Mylan Basic Information, Area Served and Competitors
    Table 54. Mylan Major Business
    Table 55. Mylan Female Contraceptives Product and Services
    Table 56. Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Mylan Recent Developments/Updates
    Table 58. Mylan Competitive Strengths & Weaknesses
    Table 59. Teva Basic Information, Area Served and Competitors
    Table 60. Teva Major Business
    Table 61. Teva Female Contraceptives Product and Services
    Table 62. Teva Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Teva Recent Developments/Updates
    Table 64. Teva Competitive Strengths & Weaknesses
    Table 65. Merck Basic Information, Area Served and Competitors
    Table 66. Merck Major Business
    Table 67. Merck Female Contraceptives Product and Services
    Table 68. Merck Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Merck Recent Developments/Updates
    Table 70. Merck Competitive Strengths & Weaknesses
    Table 71. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 72. Johnson & Johnson Major Business
    Table 73. Johnson & Johnson Female Contraceptives Product and Services
    Table 74. Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Johnson & Johnson Recent Developments/Updates
    Table 76. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 77. Lupin Pharmaceuticals Basic Information, Area Served and Competitors
    Table 78. Lupin Pharmaceuticals Major Business
    Table 79. Lupin Pharmaceuticals Female Contraceptives Product and Services
    Table 80. Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Lupin Pharmaceuticals Recent Developments/Updates
    Table 82. Lupin Pharmaceuticals Competitive Strengths & Weaknesses
    Table 83. Female Health Company Basic Information, Area Served and Competitors
    Table 84. Female Health Company Major Business
    Table 85. Female Health Company Female Contraceptives Product and Services
    Table 86. Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Female Health Company Recent Developments/Updates
    Table 88. Fuji Latex Basic Information, Area Served and Competitors
    Table 89. Fuji Latex Major Business
    Table 90. Fuji Latex Female Contraceptives Product and Services
    Table 91. Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Female Contraceptives Upstream (Raw Materials)
    Table 93. Female Contraceptives Typical Customers
List of Figure
    Figure 1. Female Contraceptives Picture
    Figure 2. World Female Contraceptives Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Female Contraceptives Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Female Contraceptives Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Female Contraceptives Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Female Contraceptives Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Female Contraceptives Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Female Contraceptives Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Female Contraceptives Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Female Contraceptives Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Female Contraceptives Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Female Contraceptives Revenue (2018-2029) & (USD Million)
    Figure 13. Female Contraceptives Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Female Contraceptives Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Female Contraceptives Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Female Contraceptives by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Female Contraceptives Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Female Contraceptives Markets in 2022
    Figure 27. United States VS China: Female Contraceptives Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Female Contraceptives Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Female Contraceptives Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Female Contraceptives Market Size Market Share by Type in 2022
    Figure 31. Contraceptive Drugs
    Figure 32. Contraceptive Devices
    Figure 33. World Female Contraceptives Market Size Market Share by Type (2018-2029)
    Figure 34. World Female Contraceptives Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Female Contraceptives Market Size Market Share by Application in 2022
    Figure 36. Personal use
    Figure 37. Hospital
    Figure 38. Female Contraceptives Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source